YA-101

· Dasher Neuroscience Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YA-101, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy [Phase 2]